3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
23
Prostatic Neoplasms
12
Colorectal Neoplasms
12
Lung Neoplasms
11
Neoplasms
9
Lymphoma
6
Hematologic Neoplasms
6
Uterine Cervical Neoplasms
5
Pancreatic Neoplasms
5
Ovarian Neoplasms
5
Triple Negative Breast Neoplasms
4
Neoplasm Metastasis
4
Melanoma
4
Hematopoietic and Lymphatic System Neoplasm
4
Urinary Bladder Neoplasms
3
Sarcoma
3
Papillomavirus Infections
3
Obesity-Related Malignant Neoplasm
3
Obesity
3
Motor Activity
3
Endometrial Neoplasms
3
Colonic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Breast Carcinoma In Situ
3
Anatomic Stage I Breast Cancer AJCC v8
3
Vulvar Neoplasms
2
Testicular Neoplasms
2
Smoking Cessation
2
Skin Carcinoma
2
Rectal Neoplasms
2
Interventions
pembrolizumab
16
Nivolumab
15
Ipilimumab
12
cemiplimab
10
aldesleukin
6
Interleukin-2
6
Cyclophosphamide
6
fludarabine
5
fludarabine phosphate
4
encorafenib
4
binimetinib
4
Blood Specimen Collection
4
avelumab
3
Sirolimus
3
trametinib
2
spartalizumab
2
lifileucel
2
dabrafenib
2
atezolizumab
2
Vemurafenib
2
Surgical Procedures, Operative
2
Specimen Handling
2
Radiotherapy
2
Prednisone
2
Niacinamide
2
Exercise
2
Everolimus
2
Dermoscopy
2
Biopsy
2
urelumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Skin Neoplasms
×
Methods
×
1 year
×
Clear all
No trials found.